Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD. Hao Q, Guyatt G. Ann Intern Med 2021;174:JC11.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hao Q, Guyatt G. Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD. Ann Intern Med 2021;174:JC11.
PMID: 33395335